[Current hazardous drug interactions].
Neuvonen
P
P
Helsingin yliopisto/HYKS, kliinisen farmakologian laitos.
D000890:Anti-Infective Agents / Q000009:adverse effects; D016589:Astemizole / Q000009:adverse effects; D001569:Benzodiazepines / Q000009:adverse effects; D002121:Calcium Channel Blockers / Q000009:adverse effects; D003524:Cyclosporins / Q000009:adverse effects; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D024841:Fluoroquinolones; D006329:Heart Conduction System / Q000187:drug effects*; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D004364:Pharmaceutical Preparations / Q000378:metabolism; D016593:Terfenadine / Q000009:adverse effects
D000890:Anti-Infective Agents; D002121:Calcium Channel Blockers; D003524:Cyclosporins; D024841:Fluoroquinolones; D006634:Histamine H1 Antagonists; D008996:Monoamine Oxidase Inhibitors; D004364:Pharmaceutical Preparations; D001569:Benzodiazepines; D016593:Terfenadine; D016589:Astemizole
Lääkkeiden uudet vaaralliset yhteisvaikutukset.